These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries. Fleck F Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339 [No Abstract] [Full Text] [Related]
8. The looming crisis in drug pricing. Delaney M GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258 [No Abstract] [Full Text] [Related]
9. Africa finds drug giants guilty of excessive pricing. AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397 [No Abstract] [Full Text] [Related]
17. The changing outlook for worldwide HIV treatment. Gonsalves G GMHC Treat Issues; 2001 Apr; 15(4):3-5. PubMed ID: 11590941 [No Abstract] [Full Text] [Related]
18. [Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi]. Krankenpfl J; 1999 Dec; 37(12):479. PubMed ID: 10734858 [No Abstract] [Full Text] [Related]
19. Glaxo drops drug prices, AIDS foundation drops suit. AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097 [No Abstract] [Full Text] [Related]
20. Activists dialog about pricing. AIDS Patient Care STDS; 1999 Apr; 13(4):247. PubMed ID: 10351896 [No Abstract] [Full Text] [Related] [Next] [New Search]